Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Symeonidis

Showing results (471-480 of 578) with videos related to

Pageof 58
Sort By:
Cancers|April 12, 2022
The Prognostic Role and Significance of Dll4 and Toll-like Receptors in Cancer DevelopmentZacharias Fasoulakis, Antonios Koutras, Thomas Ntounis, et al.
Annals of Hematology|April 27, 2002
Treatment of anemia in low-risk myelodysplastic syndromes with amifostine. In vitro testing of responseN Viniou, E Terpos, A Galanopoulos, et al.
International Journal of Hematology|November 6, 2016
A retrospective study of azacitidine treatment in patients with intermediate-2 or high risk myelodysplastic syndromes in a real-world clinical setting in GreeceVasiliki Pappa, Achilles Anagnostopoulos, Eleni Bouronikou, et al.
Medicina (Kaunas, Lithuania)|August 27, 2021
TACI Mutations in Primary Antibody Deficiencies: A Nationwide Study in GreeceIoannis Kakkas, Gerasimina Tsinti, Fani Kalala, et al.
British Journal of Haematology|May 16, 2020
Development of a core outcome set for myelodysplastic syndromes - a Delphi study from the EUMDS Registry GroupUrsula Rochau, Igor Stojkov, Annette Conrads-Frank, et al.
Plos One|October 12, 2013
Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized dataRonald Brand, Hein Putter, Anja van Biezen, et al.
Pharmacogenomics|August 9, 2019
Genomic variants in members of the Krüppel-like factor gene family are associated with disease severity and hydroxyurea treatment efficacy in β-hemoglobinopathies patientsApostolos Stratopoulos, Alexandra Kolliopoulou, Kariofyllis Karamperis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2003
Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first-line treatment in multiple myelomaM A Dimopoulos, A Pouli, K Zervas, et al.
Chirurgia (Bucharest, Romania : 1990)|March 11, 2022
The Impact of COVID-19 on the Training of Surgical Residents in Greece: Results of a Survey Conducted One Year after the Onset of the PandemicEfstathios T Pavlidis, Eirini Chrysovalantou K, Nikolaos G Symeonidis, et al.
Leukemia|June 14, 2018
A phase 3 randomized, placebo-controlled study assessing the efficacy and safety of epoetin-α in anemic patients with low-risk MDSPierre Fenaux, Valeria Santini, Maria Antonietta Aloe Spiriti, et al.
Pageof 58

Showing results (471-480 of 578) with videos related to

Sort By:
Pageof 58
Cancers|April 12, 2022
The Prognostic Role and Significance of Dll4 and Toll-like Receptors in Cancer DevelopmentZacharias Fasoulakis, Antonios Koutras, Thomas Ntounis, et al.
Annals of Hematology|April 27, 2002
Treatment of anemia in low-risk myelodysplastic syndromes with amifostine. In vitro testing of responseN Viniou, E Terpos, A Galanopoulos, et al.
International Journal of Hematology|November 6, 2016
A retrospective study of azacitidine treatment in patients with intermediate-2 or high risk myelodysplastic syndromes in a real-world clinical setting in GreeceVasiliki Pappa, Achilles Anagnostopoulos, Eleni Bouronikou, et al.
Medicina (Kaunas, Lithuania)|August 27, 2021
TACI Mutations in Primary Antibody Deficiencies: A Nationwide Study in GreeceIoannis Kakkas, Gerasimina Tsinti, Fani Kalala, et al.
British Journal of Haematology|May 16, 2020
Development of a core outcome set for myelodysplastic syndromes - a Delphi study from the EUMDS Registry GroupUrsula Rochau, Igor Stojkov, Annette Conrads-Frank, et al.
Plos One|October 12, 2013
Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized dataRonald Brand, Hein Putter, Anja van Biezen, et al.
Pharmacogenomics|August 9, 2019
Genomic variants in members of the Krüppel-like factor gene family are associated with disease severity and hydroxyurea treatment efficacy in β-hemoglobinopathies patientsApostolos Stratopoulos, Alexandra Kolliopoulou, Kariofyllis Karamperis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2003
Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first-line treatment in multiple myelomaM A Dimopoulos, A Pouli, K Zervas, et al.
Chirurgia (Bucharest, Romania : 1990)|March 11, 2022
The Impact of COVID-19 on the Training of Surgical Residents in Greece: Results of a Survey Conducted One Year after the Onset of the PandemicEfstathios T Pavlidis, Eirini Chrysovalantou K, Nikolaos G Symeonidis, et al.
Leukemia|June 14, 2018
A phase 3 randomized, placebo-controlled study assessing the efficacy and safety of epoetin-α in anemic patients with low-risk MDSPierre Fenaux, Valeria Santini, Maria Antonietta Aloe Spiriti, et al.
Pageof 58